1 Min Read
Aug 31 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd
* Unit acquired aggregate of 3.9 mln shares in Impax laboratories, for aggregate consideration of about $66.49 mln Source text: (bit.ly/2gsqFHD) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.